SCHEMBL26437500

SCHEMBL26437500

C#C/C=C\C(=C/C)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ MAPT P10636 4/20 0.40
▸ RAB9A P51151 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ CTDSP1 Q9GZU7 1/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ CYP1A1 P04798 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP1B1 Q16678 1/20 0.36
▸ WDR5 P61964 1/20 0.36
▸ HPGD P15428 3/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ LMNA P02545 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ USP2 O75604 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19831560 0.89 MAOB (0.33) MAPTCYP1B1HPGDMEN1KMT2A
SCHEMBL22458171 0.84 PTPN5 (0.38) —
SCHEMBL24577646 0.79 SMN1; SMN2 (0.32) SMN1; SMN2MAPTL3MBTL1HPGD
SCHEMBL26380790 0.78 NR4A2 (0.33) L3MBTL1KDM4E
SCHEMBL26784255 0.74 MAPT (0.41) SMN1; SMN2MAPTRAB9ANPC1CTDSP1
SCHEMBL20616726 0.73 MEN1 (0.42) MAPTHPGDMEN1KMT2AALDH1A1
SCHEMBL18789928 0.72 MAPT (0.47) SMN1; SMN2MAPTRAB9ANPC1CTDSP1
SCHEMBL24726973 0.70 KDM4E (0.45) SMN1; SMN2MAPTRAB9AHPGDMEN1
SCHEMBL24141540 0.70 — —
SCHEMBL21420061 0.70 MAPT (0.39) SMN1; SMN2MAPTL3MBTL1CYP1A2WDR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230131934-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230131934-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OSBP SMN1; SMN2 3203/4885MAPT 1888/4885RAB9A 2555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback